Dyne Therapeutics, Inc. (DYN)

NASDAQ

$15.05

$-0.24

(-1.57%)

After-Hours

Dyne Therapeutics, Inc. (DYN) Live Price Chart

Last updated: ⁦2026-10-14 21:36:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Dyne Therapeutics, Inc. (DYN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $15.05, with a market capitalisation of $2.98B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $13.88 to $27.31. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.98B
Open	$15.11
Day's High	$47.45
Day's Low	$0.30
Previous Close	$15.30
Volume	1.80M
Average Volume	2.94M
P/E Ratio	--
52-Week High	$27.31
52-Week Low	$13.88
Dividend Yield	--
Earnings Date	--

Dyne Therapeutics, Inc. (DYN) After-Hours Stock Price

Dyne Therapeutics, Inc. (DYN) is trading at $15.06 in after-hours trading as of 2026-10-14 20:16:00, down 1.60% ($0.25) from the regular-session close of $15.30.

After-hours trading shows how investors are pricing DYN after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.

Dyne Therapeutics, Inc. (DYN) 7-Day Stock Price Change

Over the past seven days, Dyne Therapeutics, Inc. (DYN) moved from $15.44 to $15.05, representing a decline of 2.50% ($0.39).

The stock traded between $14.71 and $17.31 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 4.01 million shares, up versus the previous seven-day period, indicating higher trading activity.

DYN 52-Week Price Position

Position in Range: 8.7%

52W Low$13.88

52W High$27.31

DYN is currently trading at $15.05, placing it 8.7% of the way from its 52-week low of $13.88 to its 52-week high of $27.31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Dyne Therapeutics, Inc. (DYN)?

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Dyne Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	258
Exchange	NASDAQ
Company Website	https://www.dyne-tx.com

How to Buy Dyne Therapeutics, Inc. (DYN) Stock on MEXC

Eligible investors can buy real shares of Dyne Therapeutics, Inc. (DYN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for DYN and Place Your Order

Open the RealStocks trading page and search for DYN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Dyne Therapeutics, Inc. (DYN) stock price today?

Dyne Therapeutics, Inc. (DYN) is currently trading at $ 15.05, down 1.61% ($0.25) from the previous close of $ 15.30. Intraday prices update in real time during regular trading hours.

2.Is DYN stock going up or down today?

As of 2026-10-14 20:16:00, DYN is trading at $ 15.05, down 1.61% ($0.25) from its previous close of $ 15.30. The stock has traded between $ 0.30 and $ 47.45 during today’s regular session. Past price movements do not guarantee future results.

3.What is DYN pre-market price?

As of 2026-10-14 20:16:00, DYN is trading at $ 15.22 in pre-market trading, down 0.52% ($0.08) from the previous close of $ 15.30. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is DYN after-hours price?

As of 2026-10-14 20:16:00, DYN is trading at $ 15.06 in after-hours trading, down 1.60% ($0.25) from the regular-session close of $ 15.30. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is DYN stock trading now?

DYN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does DYN sit relative to its 52-week high and low?

Over the past 52 weeks, DYN has traded between a low of $ 13.88 and a high of $ 27.31. At $ 15.05, the stock is positioned 8.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Dyne Therapeutics, Inc. in?

Dyne Therapeutics, Inc. (DYN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Dyne Therapeutics, Inc.'s market capitalisation and where is it listed?

Dyne Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 2.98B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is DYN valued in terms of P/E ratio and EPS?

DYN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.78. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Dyne Therapeutics, Inc. pay a dividend?

Dyne Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.